Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Maternal Care, Gene Expression, and the Transmission of Individual Differences in Stress Reactivity Across Generations
2001 Standout
Cochrane Database of Systematic Reviews
2003 Standout
Tiagabine
1998
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Topiramate Selectively Decreases Intracortical Excitability in Human Motor Cortex
2002
NMDA receptors in clinical neurology: excitatory times ahead
2008
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
1996 Standout
Enhancing adherence in clinical research
2005
Early Identification of Refractory Epilepsy
2000 Standout
Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology
2006 Standout
Purposeful Sampling for Qualitative Data Collection and Analysis in Mixed Method Implementation Research
2013 Standout
The Use of Contrast-Enhanced Magnetic Resonance Imaging to Identify Reversible Myocardial Dysfunction
2000 Standout
Topiramate Reduces Energy and Fat Gains in Lean (Fa/?) and Obese (fa/fa) Zucker Rats
2000
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and Men
1998 Standout
Transient left ventricular apical ballooning without coronary artery stenosis: a novel heart syndrome mimicking acute myocardial infarction
2001 Standout
Respiratory Arrest in near-Fatal Asthma
1991 Standout
Design of clinical antiepileptic drug trials
1995
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation
2005
How to improve R&D productivity: the pharmaceutical industry's grand challenge
2010 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
"Myocardial stunning"-like phenomenon during a crisis of pheochromocytoma.
1994
Theta Burst Stimulation of the Human Motor Cortex
2005 Standout
Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials
1995 Standout
Carbonic anhydrases: novel therapeutic applications for inhibitors and activators
2008 Standout
Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee
2007 Standout
Statistical Considerations in the Intent-to-Treat Principle
2000
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
Newer Anticonvulsants
2000
Calculating the “number needed to be exposed” with adjustment for confounding variables in epidemiological studies
2002
Epilepsy and cognition
2003
An update on GABAA receptors
1999
Influences on the Quality of Published Drug Studies
1996
Regulation of Adrenergic Receptor Responsiveness Through Modulation of Receptor Gene Expression
1991 StandoutNobel
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic review
2010
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Scope and Impact of Financial Conflicts of Interest in Biomedical Research
2003 Standout
A Modified Poisson Regression Approach to Prospective Studies with Binary Data
2004 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Ventilator-associated Pneumonia
2002 Standout
Coronary heart disease prevention and age inequalities: the first year of the National Service Framework for CHD.
2005
Antiepileptic drugs, clinical trials, and the marketplace
1996
Secondary Prevention for Ischemic Heart Disease
1997
Guidelines for the Early Management of Patients With Acute Ischemic Stroke
2013 Standout
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Adrenergic therapy of bronchial asthma
1986
Dexamethasone treatment for acute bacterial meningitis: how strong is the evidence for routine use?
1995
Contributions to the Theory of Nonparametric Regression, with Application to System Identification
1979
Diabetic Neuropathies
2005 Standout
Gender Differences in the Management and Clinical Outcome of Stable Angina
2006
Interference Between Units in Randomized Experiments
2007
Isoproterenol potentiates exercise-induction of Hsp70 in cardiac and skeletal muscle
1999
Multiple Testing of Hypotheses in Comparing Two Groups
1984
Pharmacological and surgical treatment of obesity.
2004
Adaptive Designs for Randomized Trials in Public Health
2009
Exactp-Values for Network Interference
2016 StandoutNobel
Clinical Perspectives on Lacosamide
2008
Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects.
1986 Standout
Some unexpected lessons from large multicenter randomized clinical trials.
1985
Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
1993
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty
1987
Pharmacokinetics and Pharmacodynamics of Topiramate
2000
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Monotherapy versus Polytherapy in Epilepsy
1995
Distributed Optimization and Statistical Learning via the Alternating Direction Method of Multipliers
2010 Standout
Topiramate vs placebo in painful diabetic neuropathy
2004
Fine-Particulate Air Pollution and Life Expectancy in the United States
2009 Standout
Catalytic Asymmetric Synthesis of Unprotected β2-Amino Acids
2021 StandoutNobel
An Algorithm for Restricted Least Squares Regression
1983
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Structure−Activity Studies on Anticonvulsant Sugar Sulfamates Related to Topiramate. Enhanced Potency with Cyclic Sulfate Derivatives
1998
Root-N-Consistent Semiparametric Regression
1988 Standout
Adaptive Seamless Phase II/III Designs—Background, Operational Aspects, and Examples
2006
A quality assessment of randomized control trials of primary treatment of breast cancer.
1986
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
Reported Methodologic Quality and Discrepancies between Large and Small Randomized Trials in Meta-Analyses
2001 Standout
Adaptive Designs: Terminology and Classification
2006
Secondary prevention after myocardial infarction: A review of long-term trials
1982
Acute and Reversible Cardiomyopathy Provoked by Stress in Women From the United States
2005 Standout
Isoproterenol potentiates exercise–induction of Hsp70 in cardiac and skeletal muscle
1999
Perampanel: expanding therapeutic options for patients with medically refractory secondary generalized convulsive seizures
2013
Synthetic Control Methods for Comparative Case Studies: Estimating the Effect of California’s Tobacco Control Program
2010 Standout
Multiple Inference and Gender Differences in the Effects of Early Intervention: A Reevaluation of the Abecedarian, Perry Preschool, and Early Training Projects
2008 Standout
Concomitant use of beta adrenergic agonists and methylxanthines
1984
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of Gordon Pledger being referenced
Number needed to treat: properties and problems - Comments
2000
Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages
1996
Topiramate Monotherapy for Partial Onset Seizures
1997
Prototype Antiepileptic Drug Clinical Development Plan
1993
Hospital investigation of men and women treated for angina
1995
Double‐Blind, Placebo‐Controlled Trial of Topiramate as Add‐on Therapy in Patients with Refractory Partial Seizures
1996
Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages
1996
Evaluation of Antiepileptic Drug Efficacy
1994
A Note on the Number Needed to Treat
1999
A Multicenter, Randomized Clinical Study to Evaluate the Effect on Cognitive Function of Topiramate Compared with Valproate as Add‐On Therapy to Carbamazepine in Patients with Partial‐Onset Seizures
2000
Double‐Blind, Placebo‐Controlled Trial of Topiramate (600 mg Daily) for the Treatment of Refractory Partial Epilepsy
1996
Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy
1996
A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy
2003
Robustness of the Wilcoxon Test to a Certain Dependency Between Samples
1974
A Unified Theory of Two-Stage Adaptive Designs
2002
A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children
1999
Consistency in Concave Regression
1976
A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures
1999
Randomization, Pk-Controlled Dosing, and Titration: An Integrated Approach for Designing Clinical Trials
1991
Felbamate for partial seizures
1991
Compliance in clinical trials: impact on design, analysis and interpretation.
1988
Phase 2 and 3 Combination Designs to Accelerate Drug Development
2005
A double-blind, randomized trial of topiramate in Lennox–Gastaut syndrome
1999
Cardiotoxic Effects in Rats and Rabbits Treated with Terbutaline Alone and in Combination with Aminophylline
1983
Determinants of resistance to the cardiotoxicity of isoproterenol in rats
1983
The FDA's Critique of the Anturane Reinfarction Trial
1980